CORT - Company ID 0001088856
The table below shows CORCEPT THERAPEUTICS INC's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $108.74M | $125.14M | $102.75M | $89.82M | $137.29M | $128.59M |
| Short-term investments | $229.45M | $296.55M | $239.48M | $232.94M | $243.05M | $344.57M |
| Receivables | $39.07M | $69.63M | $64.57M | $61.82M | $59.72M | $53.84M |
| Inventory | $12.89M | $12.35M | $12.28M | $14.37M | $8.05M | $8.35M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $426.03M |
| $541.13M |
| $443.11M |
| $438.50M |
| $466.98M |
| $560.85M |
| Property, plant & equipment | $3.17M | $2.09M | $2.35M | $2.54M | $2.93M | $1.47M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $814.88M | $823.61M | $801.72M | $846.46M | $784.26M | $714.55M |
| Accounts payable | $33.31M | $34.45M | $23.52M | $27.95M | $18.58M | $19.48M |
| Total current liabilities | $149.19M | $172.26M | $144.66M | $143.07M | $126.22M | $100.75M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $176.89M | $191.71M | $165.93M | $163.17M | $145.42M | $118.31M |
| Retained earnings | $611.63M | $619.10M | $599.43M | $564.28M | $512.99M | $465.78M |
| Total equity | $637.99M | $631.90M | $635.79M | $683.28M | $638.84M | $596.24M |